dalteparin has been researched along with Drug Abuse, Intravenous in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boedeker, CC | 1 |
| Ridder, GJ | 1 |
| Weerda, N | 1 |
| Maier, W | 1 |
| Klenzner, T | 1 |
| Schipper, J | 1 |
| Baldeweg, SE | 1 |
2 other studies available for dalteparin and Drug Abuse, Intravenous
| Article | Year |
|---|---|
[Etiology and therapy of the internal jugular vein thrombosis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Cellulitis; Diagnosis, Differe | 2004 |
Arterial and venous disease and deep vein thrombosis. Injecting drug use is major risk factor for deep vein thrombosis.
Topics: Anticoagulants; Dalteparin; Humans; Leg; Risk Factors; Substance Abuse, Intravenous; Venous Thrombos | 2000 |